- Home
- CDNA vs SLI Comparison
CDNA vs SLI Comparison
Compare CDNA & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- SLI
- Stock Information
- Founded
- CDNA 1998
- SLI 1998
- Country
- CDNA United States
- SLI Canada
- Employees
- CDNA N/A
- SLI N/A
- Industry
- CDNA Medical Specialities
- SLI Major Chemicals
- Sector
- CDNA Health Care
- SLI Industrials
- Exchange
- CDNA Nasdaq
- SLI Nasdaq
- Market Cap
- CDNA 712.2M
- SLI 595.8M
- IPO Year
- CDNA 2014
- SLI N/A
- Fundamental
- Price
- CDNA $15.19
- SLI $4.09
- Analyst Decision
- CDNA Buy
- SLI Strong Buy
- Analyst Count
- CDNA 8
- SLI 3
- Target Price
- CDNA $26.86
- SLI $4.38
- AVG Volume (30 Days)
- CDNA 1.3M
- SLI 3.8M
- Earning Date
- CDNA 11-03-2025
- SLI 11-11-2025
- Dividend Yield
- CDNA N/A
- SLI N/A
- EPS Growth
- CDNA N/A
- SLI N/A
- EPS
- CDNA 1.00
- SLI N/A
- Revenue
- CDNA $340,826,000.00
- SLI N/A
- Revenue This Year
- CDNA $12.73
- SLI N/A
- Revenue Next Year
- CDNA $11.90
- SLI N/A
- P/E Ratio
- CDNA $15.23
- SLI N/A
- Revenue Growth
- CDNA 14.72
- SLI N/A
- 52 Week Low
- CDNA $10.96
- SLI $1.08
- 52 Week High
- CDNA $32.76
- SLI $4.26
- Technical
- Relative Strength Index (RSI)
- CDNA 60.38
- SLI 70.08
- Support Level
- CDNA $14.28
- SLI $3.26
- Resistance Level
- CDNA $15.21
- SLI $4.08
- Average True Range (ATR)
- CDNA 0.60
- SLI 0.32
- MACD
- CDNA 0.02
- SLI 0.08
- Stochastic Oscillator
- CDNA 72.48
- SLI 88.02
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.